Search

Your search keyword '"Ahmad, Azura"' showing total 30 results

Search Constraints

Start Over You searched for: Author "Ahmad, Azura" Remove constraint Author: "Ahmad, Azura"
30 results on '"Ahmad, Azura"'

Search Results

2. 5D BIM Implementation to Overcome Cost Management Issues in Upstream Oil and Gas Projects in Malaysia: A Review

3. Polyhydroxyalkanoate Biosynthesis from Waste Cooking Oils by Cupriavidus necator Strains Harbouring phaCBP-M-CPF4.

4. Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial

5. 5D BIM Implementation to Overcome Cost Management Issues in Upstream Oil and Gas Projects in Malaysia: A Review.

6. Supplementary Figure S3 from Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis

7. Supplementary Table S2 from Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis

8. Supplementary PLS from Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis

9. Data from Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis

10. Randomized Trial of Tepotinib Plus Gefitinib Versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis

11. Application of 5D BIM to improve the oil and gas project cost performance.

12. Plasticity and Strength Behaviour of Marine Clay Stabilized with Waste Steel Dust for Soil Improvement Works

13. Abstract CT538: Tepotinib + gefitinib in patients with EGFR-mutant NSCLC with MET amplification: Final analysis of INSIGHT

15. Resistivity Determination of Railway Track's Subgrade.

18. Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes

20. Abstract CT193: Tepotinib + gefitinib vs chemotherapy in MET-amplified EGFR-mutant non-small cell lung cancer (NSCLC): Predefined subgroup analysis of a Phase Ib/II study

21. Abstract CT193: Tepotinib + gefitinib vs chemotherapy inMET-amplified EGFR-mutant non-small cell lung cancer (NSCLC): Predefined subgroup analysis of a Phase Ib/II study

23. Oncologist-led BRCAcounselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes

25. Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or METamplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial

26. Patients with EGFR mutant (m) MET-altered NSCLC receiving tepotinib with an EGFR tyrosine kinase inhibitor (TKI): A case series.

27. EFFECTIVE SHEAR STRENGTH PARAMETERS OF SOIL SAMPLES TAKEN FROM SLOPE FAILURE ALONG THE KULIM - BALING ROAD.

28. Verification of Indirect Tensile Strength of Weathered Mudstone from H-Ometer Test Using Sigma/W Model

30. Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes.

Catalog

Books, media, physical & digital resources